Literature DB >> 19055171

Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole.

Bruce P Burnett1, Calvin M Mitchell.   

Abstract

Commercially available topical formulations consisting of iodoquinol 1%-hydrocortisone acetate 2%, ciclopirox 0.77%, and clotrimazole 1%-betamethasone dipropionate 0.5% were assessed for their antimicrobial activity against cultures of Micrococcus luteus, Propionibacterium acnes, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Corynebacterium aquaticum, Trichophyton mentagrophytes, Malassezia furfur, Microsporum canis, Candida albicans, Trichophyton rubrum, or Epidermophyton floccosum. At 1 and 5 minutes following inoculation into suspensions of each product, aliquots were removed, serially diluted, and plated onto appropriate agar to determine the log reduction in colony-forming units (CFUs) for each organism. Iodoquinol 1% produced the broadest and greatest antimicrobial activity as measured by a 3-log reduction of CFU, active against all microbes tested following incubation times of 1 or 5 minutes, except M luteus. By contrast, ciclopirox 0.77% and clotrimazole 1% showed activity against P aeruginosa and T rubrum, with ciclopirox also killing M luteus, P acnes, M canis, C albicans, and E floccosum at 5 minutes. Iodoquinol 1%-hydrocortisone acetate 2% also was the only product that showed effective antibacterial reduction of MRSA at 1 minute.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19055171

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  In vitro fungicidal photodynamic effect of hypericin on Trichophyton spp.

Authors:  Manuel Pablo Paz-Cristobal; Yolanda Gilaberte; Carmen Alejandre; Julián Pardo; M José Revillo; Antonio Rezusta
Journal:  Mycopathologia       Date:  2014-08-17       Impact factor: 2.574

2.  A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.

Authors:  Rowena Alves Coelho; Luna Sobrino Joffe; Gabriela Machado Alves; Maria Helena Galdino Figueiredo-Carvalho; Fábio Brito-Santos; Ana Claudia Fernandes Amaral; Marcio L Rodrigues; Rodrigo Almeida-Paes
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

3.  Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents.

Authors:  Jennifer M Colquhoun; Rachel A F Wozniak; Paul M Dunman
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

4.  Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box.

Authors:  Gina Wall; Natalia Herrera; José L Lopez-Ribot
Journal:  J Fungi (Basel)       Date:  2019-10-01

5.  Identification of two potential inhibitors of Sporothrix brasiliensis and Sporothrix schenckii in the Pathogen Box collection.

Authors:  Luana Pereira Borba-Santos; Taissa Vila; Sonia Rozental
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.